<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Mail.com: Cholesterol</title>
    <link>http://www.mail.com/subjects/170624-cholesterol.html</link>
    <description>Mail.com - the best personalized free web-based Email</description>
    <language>en</language>
    <dc:language>en</dc:language>
    <image>
      <title>Mail.com: Cholesterol</title>
      <url>http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png</url>
      <link>http://www.mail.com/subjects/170624-cholesterol.html</link>
    </image>
    <item>
      <title>Mediterranean-style diets found to cut heart risks</title>
      <link>http://www.mail.com/entertainment/lifestyle/1914726-mediterranean-style-diets-to-cut-heart-risks.html</link>
      <description>Pour on the olive oil, preferably over fish and vegetables: One of the longest and most scientific tests of a Mediterranean diet suggests this style of eating can cut the chance of suffering heart-related problems, especially strokes, in older people at high risk of them. 
                   The study lasted five years and involved about 7,500 people in Spain. Those who ate ...</description>
      <pubDate>Mon, 25 Feb 2013 19:32:03 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/entertainment/lifestyle/1914726-mediterranean-style-diets-to-cut-heart-risks.html</guid>
      <dc:date>2013-02-25T19:32:03Z</dc:date>
    </item>
    <item>
      <title>Merck settles investor suits on cholesterol drugs</title>
      <link>http://www.mail.com/scitech/health/1892112-merck-settles-investor-suits-cholesterol-drugs.html</link>
      <description>TRENTON, N.J. (AP) — Merck &amp; Co. has agreed to pay $688 million to settle two long-running lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales. 
                   Merck, the world's third biggest drugmaker by revenue, said Thursday that it agreed to the settlement because it's in ...</description>
      <pubDate>Thu, 14 Feb 2013 22:21:07 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1892112-merck-settles-investor-suits-cholesterol-drugs.html</guid>
      <dc:date>2013-02-14T22:21:07Z</dc:date>
    </item>
    <item>
      <title>Merck warns docs to stop prescribing Tredaptive</title>
      <link>http://www.mail.com/scitech/health/1813646-merck-warns-docs-to-prescribing-tredaptive.html</link>
      <description>Drugmaker Merck &amp; Co. is suspending its sale of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects. 
                   The Whitehouse Station, N.J., company said Friday it is telling doctors to quit prescribing the tablets, which are not approved in the United States, and i...</description>
      <pubDate>Fri, 11 Jan 2013 15:06:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1813646-merck-warns-docs-to-prescribing-tredaptive.html</guid>
      <dc:date>2013-01-11T15:06:00Z</dc:date>
    </item>
  </channel>
</rss>

